Dec 20, 2024, 15:57
Yakup Ergün: Ponsegromab for the Treatment of Cancer Cachexia
Yakup Ergün, Medical Oncologist at Bower Hospital, shared an by John D. Groarke et al. published in NEJM, on X:
“Ponsegromab for the Treatment of Cancer Cachexia.
The placebo-controlled phase 2 study presented at ESMO 2024 showed that Ponsegromab, a monoclonal antibody developed against GDF-15, increases weight gain and reduces cachexia symptoms.”
Ponsegromab for the Treatment of Cancer Cachexia | NEJM
Authors: John D. Groarke et al.
Aditi R. Saxena
Andrew E. Hendifar
cancer
Carrie A. Northcott
Eric J. Roeland
Isik Karahanoglu
Jeffrey Crawford
John D. Groarke
Koichi Takayama
Magdalena A. Harrington
Marie Fallon
Michelle Rossulek
OncoDaily
Oncology
Ponsegromab
Richard F. Dunne
Ruolun Qiu
Shannon Lubaczewski
Susie M. Collins
Tateaki Naito
Timothy Asmis
Yakup Ergün
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 20, 2024, 15:57
Dec 20, 2024, 15:46
Dec 20, 2024, 15:37
Dec 20, 2024, 15:28
Dec 20, 2024, 14:38
Dec 20, 2024, 14:19
Dec 20, 2024, 14:12
Dec 20, 2024, 14:04